107 related articles for article (PubMed ID: 2680433)
1. Safety of propranolol in portal hypertension. Conventional and long acting formulations.
Hayes PC
Drugs; 1989; 37 Suppl 2():70-3; discussion 74-6. PubMed ID: 2680433
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension.
Douglas-Jones AP
J Int Med Res; 1979; 7(3):221-3. PubMed ID: 378731
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients.
Khan AU
J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of long acting propranolol. Implications for therapeutic use.
Nace GS; Wood AJ
Clin Pharmacokinet; 1987 Jul; 13(1):51-64. PubMed ID: 3304770
[TBL] [Abstract][Full Text] [Related]
6. Portal hypertension, propranolol, and hepatic encephalopathy.
Lancet; 1982 Oct; 2(8303):879-80. PubMed ID: 6126739
[No Abstract] [Full Text] [Related]
7. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
[TBL] [Abstract][Full Text] [Related]
8. Propranolol in the treatment of portal hypertension: a caution.
Conn HO
Hepatology; 1982; 2(5):641-4. PubMed ID: 6981577
[No Abstract] [Full Text] [Related]
9. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Bañares R; Moitinho E; Matilla A; García-Pagán JC; Lampreave JL; Piera C; Abraldes JG; De Diego A; Albillos A; Bosch J
Hepatology; 2002 Dec; 36(6):1367-73. PubMed ID: 12447861
[TBL] [Abstract][Full Text] [Related]
10. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
Carter BL; Gersema LM; Williams GO; Schabold K
Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
[TBL] [Abstract][Full Text] [Related]
11. Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses.
Carroll JD; Reidy M; Savundra PA; Cleave N; McAinsh J
Cephalalgia; 1990 Apr; 10(2):101-5. PubMed ID: 2193712
[TBL] [Abstract][Full Text] [Related]
12. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis.
Ozsoylu S; Koçak N; Demir H; Yüce A; Gürakan F; Ozen H
Turk J Pediatr; 2000; 42(1):31-3. PubMed ID: 10731866
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological therapy of portal hypertension--focused on Korean data].
Baik SK
Korean J Gastroenterol; 2005 Jun; 45(6):381-6. PubMed ID: 15973071
[TBL] [Abstract][Full Text] [Related]
14. Long term effects of propranolol on portal pressure in cirrhotic patients.
Orban-Schiopu AM; Popescu CR
Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
[TBL] [Abstract][Full Text] [Related]
15. Effects of propranolol and nitroglycerin on portal pressure and the mechanism of their reducing portal pressure.
Terada M; Notsumata K; Unoura M; Kobayashi K; Hattori N
J Gastroenterol Hepatol; 1989; 4 Suppl 1():254-8. PubMed ID: 2519070
[No Abstract] [Full Text] [Related]
16. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
[TBL] [Abstract][Full Text] [Related]
17. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
Kubik MM; Gill B; Dawes PM
Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
[TBL] [Abstract][Full Text] [Related]
18. [Medical therapy of portal hypertension].
Baldassarre G; Ventrella F; Gadaleta CD
Clin Ter; 1986 May; 117(4):355-60. PubMed ID: 3731740
[No Abstract] [Full Text] [Related]
19. PORTAL HYPERTENSION TREATMENT WITH CANDESARTAN PLUS PROPRANOLOL FOR NINE MONTHS RESTORES NORMAL PORTAL CIRCULATION HEMODYNAMIC PATTERN.
Abd Alla MD; Eid EMM; Soliman AIA; Elhawary MA; Kilany YF; Abd-Almonaem G; Bayoumi SS; Moursy MRA; Al-Zaem FAM
J Egypt Soc Parasitol; 2016 Dec; 46(3):587-604. PubMed ID: 30230756
[TBL] [Abstract][Full Text] [Related]
20. Prevention of first variceal bleeding: new prospects.
Hamid S; Jafri W
J Pak Med Assoc; 1992 Feb; 42(2):47-51. PubMed ID: 1349361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
